Ajanta Pharma Q1 PAT seen up 9.1% YoY to Rs 190.5 cr: Nirmal Bang

Nirmal Bang has come out with its first quarter (April - June’ 24) earnings estimates for the Pharmaceutical sector. The brokerage house expects Ajanta Pharma to report net profit at Rs 190.5 crore up 9.1% year-on-year (up 55.8% quarter-on-quarter).

Net Sales are expected to increase by 9.6 percent Y-o-Y (up 18.2 percent Q-o-Q) to Rs 1,042.3 crore, according to Nirmal Bang.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 10.5 percent Y-o-Y (up 64 percent Q-o-Q) to Rs 244.9 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.